Published study details proof-of-concept for covid-19 detection via saliva screening

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) announced today that researchers from the qimr berghofer medical research institute in brisbane, australia, collaborated with agilent experts on a proof-of-concept ftir-based saliva covid-19 testing workflow using the agilent cary 630 ftir spectrometer. the study investigated the pathophysiological response to a covid-19 infection through atr-ftir spectroscopy. the researchers acquired infrared spectra of saliva samples f
A Ratings Summary
A Quant Ranking